Skip to main content

News

March 30, 2021
Pivotal study to evaluate the use of novel liquid embolic versus standard of care in treating malignant and benign hypervascular tumors.
March 30, 2021
Fluidx Medical’s GPX™ embolic device demonstrates versatility and control in oncology clinical use.
March 25, 2021
Data presented at SIR 2021 confirm safety and dose-efficacy relationship
March 18, 2021
Treatment is the only radioembolization treatment approved for U.S. patients with hepatocellular carcinoma
March 16, 2021
Patients with debilitating bone tumors experienced improved quality of life in as little as 3 days.
March 04, 2021
NEWS PROVIDED BY GO2 Foundation for Lung Cancer  SAN CARLOS, Calif. and WASHINGTON, March 4, 2021 /PRNewswire/ -- GO2 Foundation for Lung Cancer (GO2 Foundation) announced its leadership in the launch of an important…
March 01, 2021
Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management
February 17, 2021
LONDON, Feb. 17, 2021 /PRNewswire/ -- Theragnostics, which is developing molecular radiotherapy for imaging and treating a broad range of cancers, today announces a research collaboration with Essen University Hospital to examine…
February 05, 2021
Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment of the disease, with experts issuing stark warnings on liver cancer survival rates.
February 02, 2021
Join us in Miami for the practical IO meeting of the year!
Back to Top